Section Arrow
NBTX.NASDAQ
- Nanobiotix SA
Quotes are at least 15-min delayed:2026/06/06 22:22 EDT
Regular Hours
Last
 35.46
-1.45 (-3.93%)
Day High 
36.44 
Prev. Close
36.91 
1-M High
57.14 
Volume 
49.65K 
Bid
17.58
Ask
36.6
Day Low
34.6 
Open
36.44 
1-M Low
33.1 
Market Cap 
1.87B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 39.02 
20-SMA 43.88 
50-SMA 37.06 
52-W High 57.14 
52-W Low 4.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.50/0.24
Enterprise Value
1.96B
Balance Sheet
Book Value Per Share
-1.94
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
29.64M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BCDABioCardia Inc.1.03+0.111+12.08%-- 
BGMSBio Green Med Solution Inc1.5+0.44+41.51%0.3PE
CMNDClearmind Medicine Inc.3.98+1.07+36.77%-- 
ADTXAditxt Inc.0.0621-0.0149-19.35%-- 
RXRXRecursion Pharmaceuticals3.315-0.485-12.76%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without addingburden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.